These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7438037)

  • 21. Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labeled with doxorubicin or protein A.
    Rettenmaier MA; Stratton JA; Berman ML; Senyei A; Widder K; White DB; DiSaia PJ
    Gynecol Oncol; 1987 May; 27(1):34-43. PubMed ID: 3570048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.
    Jain SK; Awasthi AM; Jain NK; Agrawal GP
    J Control Release; 2005 Oct; 107(2):300-9. PubMed ID: 16095748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat.
    Gallo JM; Hung CT; Gupta PK; Perrier DG
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):305-26. PubMed ID: 2810070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable microparticulate system of captopril.
    Dandagi PM; Mastiholimath VS; Patil MB; Gupta MK
    Int J Pharm; 2006 Jan; 307(1):83-8. PubMed ID: 16310990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The preparation and the in vitro release of OANO-1 microspheres].
    Yang F; Bi GW; Long XY; Yu ZM; Yang WS; Feng LP
    Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(13):992-4. PubMed ID: 16161426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and characterization of temperature-sensitive poly(N-isopropylacrylamide)-b-poly(D,L-lactide) microspheres for protein delivery.
    Liu SQ; Yang YY; Liu XM; Tong YW
    Biomacromolecules; 2003; 4(6):1784-93. PubMed ID: 14606909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled-release of doxorubicin from poly(lactide-co-glycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells.
    Mallery SR; Pei P; Kang J; Ness GM; Ortiz R; Touhalisky JE; Schwendeman SP
    Anticancer Res; 2000; 20(5A):2817-25. PubMed ID: 11062689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable microspheres. I. Duration of action of dextranase entrapped in polyacrylstarch microparticles in vivo.
    Artursson P; Edman P; Sjöholm I
    J Pharmacol Exp Ther; 1984 Dec; 231(3):705-12. PubMed ID: 6502524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albumin microspheres as vehicles for the sustained and controlled release of doxorubicin.
    Jones C; Burton MA; Gray BN
    J Pharm Pharmacol; 1989 Dec; 41(12):813-6. PubMed ID: 2576441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of albumin and casein microspheres as a carrier for doxorubicin.
    Chen Y; Willmott N; Anderson J; Florence AT
    J Pharm Pharmacol; 1987 Dec; 39(12):978-85. PubMed ID: 2894445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albumin microspheres as a drug delivery system for dexamethasone: pharmaceutical and pharmacokinetic aspects.
    Dilova V; Shishkova V
    J Pharm Pharmacol; 1993 Nov; 45(11):987-9. PubMed ID: 7908043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres.
    Jones C; Burton MA; Gray BN
    Br J Cancer; 1989 May; 59(5):743-5. PubMed ID: 2736208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
    Widder KJ; Morris RM; Poore G; Howard DP; Senyei AE
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):579-81. PubMed ID: 6941258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of adriamycin magnetic albumin microspheres and their experimental antitumor effects in vitro and in vivo.
    Tao K; Chen D; Chen J; Tian Y; Wu Z; Wang X; Yang X
    J Tongji Med Univ; 1999; 19(4):295-9. PubMed ID: 12938522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats.
    Gupta PK; Hung CT
    Life Sci; 1990; 46(7):471-9. PubMed ID: 2304381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue.
    Willmott N; Cummings J
    Biochem Pharmacol; 1987 Feb; 36(4):521-6. PubMed ID: 3827939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats.
    Gupta PK; Hung CT; Rao NS
    J Pharm Sci; 1989 Apr; 78(4):290-4. PubMed ID: 2724092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of stabilization temperature on the degradation of adriamycin in albumin microspheres.
    Law SL; Chiang CH; Lin FM; Teh GW
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(3):613-29. PubMed ID: 1760494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition.
    Widder KJ; Marino PA; Morris RM; Howard DP; Poore GA; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):141-7. PubMed ID: 6682772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.